Citiranja zapisa
APA način citiranja (7. izdanje)
Michot, J., Chavez, J. C., Carpio, C., Ferrari, S., Feldman, T. A., Morillo, D., . . . Nastoupil, L. (2022). S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY. Wiley.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
Čikaški stil citiranja (17. izdanje)
Michot, J.-M, et al. S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY. Wiley, 2022.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
MLA način citiranja (9. izdanje)
Michot, J.-M, et al. S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY. Wiley, 2022.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
Upozorenje: Ovi citati možda nisu uvijek 100% točni.